Rona Therapeutics

Developer of oligonucleotide therapeutics to treat multiple diseases

placeShanghai, Shanghai, China calendar_todayFounded 2021 language ronatherapeutics.com

Social engagement

Social engagement: 599 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include LongRiver Investments.

Investor typeCountShare
Venture capital444%
Bank & private debt111%
Other / undisclosed444%
Coming soon